PATENTS

Medlab owns and runs an Office of the Gene Technology Regulator (OGTR) approved PC2 Biologic facility in NSW, Australia.


This is the primary site for research projects.


Presently we are involved in early phase drug discovery in 5 key areas:

  1. Obesity
  2. Chronic Kidney Disease
  3. Depression
  4. Musculoskeletal muscle loss associated with ageing
  5. Non-opioid pain management

 

Medlab has multiple patents pending on our products:

 

Product

Jurisdiction

Description

Application Number

Filling Date

Status

NAFLD Australia Probiotic compositions and uses thereof for treatment of obesity-related disorders 2015258769 11/5/15 11/5/15 Filed
ImmuneBiotic Australia Probiotic uses and uses thereof (VI) 2016901953 24/5/16 Provisional application filed
NRGBiotic Australia Probiotic combinations and uses thereof Probiotic combinations and uses thereof 21/5/15 Accepted
NRGBiotic Australia Probiotic combinations and uses thereof (innovation) 2015100928 6/8/15 Granted
EnBiotic Australia (Innovation) Probiotic and enzyme containing compositions and uses thereof 2015100952 17/7/15 Granted
CKD Australia Probiotic compositions and uses thereof (i) 2016903493 1/9/16 Provisional application field
Cannabinoids Australia Probiotic compositions and uses thereof (ii) 2016903491 1/9/16 Provisional application field
ORSbiotic Australia (Innovation) Probiotic compostitions for rehydration 2016100500 2/5/16 Granted
GastroDaily Australia (Innovation) Yeast-containing compositions for gastrointestinal health 2016100499 2/5/16 Granted
W8Biotic Australia (Innovation) Probiotic composition for weight management 2016100501 2/5/16 Granted
W8Biotic Australia (Innovation) Probiotic composition for weight management 2016100501 2/5/16 Granted
Nanocelle Australia Transmucosal and transdermal delivery systems PCT/US2016/020468 2/3/16 Filed
Cannabis Australia Protection of plant extracts and compounds from degradation 2016901758 11/5/16 Provisional application filed
NanocCelle Bacteria Australia NanocCelle Bacteria In draft 11/5/16 In draft